WO2007075597A2 - Produit de cosmetologie pour la peau et les cheveux - Google Patents

Produit de cosmetologie pour la peau et les cheveux Download PDF

Info

Publication number
WO2007075597A2
WO2007075597A2 PCT/US2006/048289 US2006048289W WO2007075597A2 WO 2007075597 A2 WO2007075597 A2 WO 2007075597A2 US 2006048289 W US2006048289 W US 2006048289W WO 2007075597 A2 WO2007075597 A2 WO 2007075597A2
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
source
oil
cyclomethicone
volume
Prior art date
Application number
PCT/US2006/048289
Other languages
English (en)
Other versions
WO2007075597A3 (fr
Inventor
Tina M. Ekker
Original Assignee
Ekker Tina M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ekker Tina M filed Critical Ekker Tina M
Publication of WO2007075597A2 publication Critical patent/WO2007075597A2/fr
Publication of WO2007075597A3 publication Critical patent/WO2007075597A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Definitions

  • This invention relates to topical compositions containing silicone emollients, such as dimethicone and/or cyclomethicone, and methods of use for regulating the condition of skin or hair, especially conditions related to hydration.
  • silicone emollients such as dimethicone and/or cyclomethicone
  • Cosmetology products for use on skin e.g., a lotion
  • Cosmetology products for use on hair e.g., shampoo, conditioner, hair gel and hair spray
  • hair e.g., shampoo, conditioner, hair gel and hair spray
  • bath oils and salts are well known in the art.
  • present formulations are typically intended for application to either hair or skin, but not both.
  • cosmetology solution that could be used as a lotion for smoothing skin when applied directly, or as a hair detangler that improves shine when applied to hair in a wet or dry condition, or that could be used as a bath oil for indirectly smoothing skin.
  • a cosmetology solution that could treat numerous disease conditions affecting the skin would be desirable.
  • the present invention provides an improved cosmetology solution for treatment of skin and/or hair.
  • compositions for external application to the skin and/or hair may be used to treat burns, particularly minor burns, sunburns, eczema, psoriasis, dry or bleeding cuticles, dry or rough skin, athletes foot, razor rash or razor burn, cold sores; dry or chapped lips, dry or frayed hair, and/or combinations thereof.
  • a composition of the invention may also be used to treat pain associated with the skin or joints of the subject
  • compositions of the invention include a topical composition comprising: a mixture of dimethicone and cyclomethicone, wherein the mixture is from about 60:40 to about 70:30 (vol.:vol.) dimethicone:cyclomethicone; mineral oil; Aloe vera gel; a vitamin E source; a vitamin A source; and water.
  • the mineral oil, Aloe vera gel, and/or vitamin E source may be in an amount from about 0.2% to about 4% of the volume of the dimeticone and cyclomethicone mixture.
  • the vitamin A source may be in an amount from about
  • compositions of the invention may contain a scented oil, for example, in an amount of from about 0.1% to about 2% of the volume of the dimeticone and cyclomethicone mixture.
  • the invention also relates to a method of maintaining or improving a skin or hair condition by applying a composition of the invention to the skin and/or hari of a subject, for example, a mammal, such as a human, thought to be. in need of such treatment.
  • FIG. 1 shows the affect of three days of treatment on eczema, with the photograph on November 30, 2006, illustrating the skin prior to treatment and the photographs on December 2 and 3 illustrate the beneficial effect, of the composition. ⁇
  • the invention relates to a topical composition that is beneficial in the treatment of eczema, psoriasis, and dermatitis. Surprisingly, the composition is also effective in the treatment of hair and other skin conditions.
  • compositions have been found to make the user's hair more manageable, easier to comb out (detangled), softer, in better condition, improve split ends, and improve the shine or appearance of the hair.
  • the formulation also works extremely well for hair that is blow dried, hot flat ironed and curled with hot rollers, particularly, when the product is applied prior to the use of these items.
  • the product uses the product on the skin to give that it was able to relieve dry skin, make the skin softer to the touch, and reduce the signs of aging by reducing the appearance of fine lines and wrinkles on the chest, face and neck.
  • the product is also beneficial after shaving to help eliminate chaffing and/or razor rash keeping the skin soft and smooth.
  • the product provides a bath treatment that may be added to warm bath water to soften and smooth the skin, and may remove the need to use a cream or a lotion after bathing.
  • the invention relates to a leave-in conditioner for hair, an oil, cream or lotion for the skin, and a bath oil.
  • the oil, cream or lotion for the skin may be used alone or under make-up and other moisturizers or creams as desired.
  • compositions of the invention are believed to be effective for the treatment for eczema and dermatitis.
  • Aloe Vera means a compound or composition comprising an extract, exudate, gel, juice, sap or latex derived from a plant of the Aloe genus (e.g , "Aloe vera,” ' ' with Aloe barbadensis
  • Aloe vera is a clear colorless semi-solid Aloe Gel that has been stabilized. Aloe Vera is particularly rich in vitamins A, C, & E.
  • dimethicone means a mixture of fully methylated, linear siloxane polymers conforming to the general chemical structure: R 3 -Si-O- [SiOR 2 I n -Si-Ra, wherein R is an alkyl group having from one to thirty carbon atoms, preferably R is methyl or ethyl, and wherein n is an integer from 1 to about 10,000 depending on the desired molecular weight.
  • the dimethicone is of medium viscosity, e.g., 50 centistokes (cSt) to 1,000 cSt, including 50, 100, 200, 350, 500, or 1,000 cSt dimethicone.
  • Dimethicone for use in the composition may be obtained from Clearco Products, particularly 350 cSt. As will be apparent in light of the teachings herein dimethicone having a low viscosity, medium viscosity, high viscosity and mixtures thereof may also be utilized (see also U.S. Patent 6,238,678).
  • cyclomethicone means a mixture of unmodified silicones that generally possess a cyclical structure. Cyclomethicone may be obtained from Clearco Products, particularly a -volatile polydimethylcyclosiloxane (cyclomethicone) sold by Clearco Products as Cyclo- 2244 (D-4), which is composed mainly of octamethylcyclotetrasiloxane (CAS#556-67-2). As will be apparent in light of the teachings herein D-4, D-5, D-6 and mixtures thereof may also be utilized (see also U.S. Patent 6,238, : 678).
  • mineral oil means an oil or liquid petrolatum that is chemically inert, transparent, colorless oil composed mainly of alkanes and cyclic paraffins.
  • vitamin E source '1' ' means an oil derived from a source having vitamin E or an oil to which vitamin E has been added, wherein the oil is enriched for vitamin E.
  • vitamin E sources include, but are not limited to, Soybean oil, Coconut oil, Wheat germ oil, Sunflower oil, Hazelnut oil, Walnut oil, Peanut oil, and Olive oil.
  • a “vitamin E source” is a "liquid vitamin E” based on a soybean oil having approximately 12,000 international units (IUs) per two ounces, or 12,000IUs per 8 oz, where one IU is equal to 0.67 milligram of d-alpha-tocopherol.
  • vitamin A source means an oil derived from a source having vitamin A or an oil to which vitamin A has been added, wherein the oil is enriched for vitamin A.
  • vitamin A sources include, but are not limited to, a liquid vitamin A utilizing Soybean oil as the carrier or vehicle and having vitamin A derived from fish liver in the form of retinol palmitate.
  • a "scented oil” means an aromatic oil or an essential oil.
  • an "essential oiF means any volatile oil that imparts the characteristic odor of a plant.
  • essential oils includes, but is not limited to, Angelica Root, Anise, Peru Balsam, Basil, Bay, Bay Laurel, Beeswax, Benzoin, Bergam ⁇ t, Bergamot Mint, Bois-de-rose, Boronia, Cajeput, Car.damum, Carrot Seed, Cedarwood, Chamomile, Cinnamon, Citronella, Clary Sage, Clove, Coriander, Cypress, Dill, Elemi, Eucalyptus, Fennel, Fir Needle, Frankincense, Galbanum, Geranium, Ginger, Grapefruit, Helichrysurn, Hyssop, Immortelle, Jasmine, Juniper Berry, Kanuka, Lavender, Lavendin, Lemon, Lemongrass, Lime, Linden Blossom, Mandarin, Manuka,
  • a "Zinc source” means a source of the element zinc (Zn), including, but not limited to, zinc derived from dairy products, beans and lentils, yeast, nuts, seeds and wholegrain cereals, where pumpkin seeds provide one of the most concentrated natural sources of food based zinc.
  • the zinc source is dissolved or suspended in a liquid, oil or water, prior to being added to the composition of the invention.
  • Treating does not mean a complete cure. It means that the symptoms of the underlying disease are reduced, delayed, or prevented, or that one or more of the underlying cellular, physiological, or biochemical causes or mechanisms causing the symptoms are reduced, delayed, or prevented. It is understood that reduced, delayed, or prevented, as used in this context, means relative to the untreated state of the disease, including the molecular state of the disease, not just the physiological state of the disease.
  • lavender oil is used to prepare a composition useful for treating pain, particularly pain associated with arthritis.
  • Exemplary ratios of the dimethicone to the cyclomethicone are from about 60:40 to about 70:30 (vol.:vol.), or about 61:39 to about 69:31 (vol.:vol.), or about 62:38 (vol.:vol.) to about 68:32, or about 63:37 to about 67:33, or about
  • the content of other ingredients in this mixture may be from about 0.2% to about 15% (volJvol.) of the mixture, or from about 1% to about 14% (vol./vol.), or from about 3% to about 13% (vol./vol.), or about 4% to about 13%, or about 6% to about ; 13%, or about 12% to about 13%, or about 1%, about 3%, about 4%, about 6%, about 12%, about 13%, or about 14% of the volume of the dimeticone and cyclomethicone mixture (e.g., 12 ounces of dimethicone and 6 ounces of cyclomethicone yields approximately 480 ml of the dimethicone and cyclomethicone mixture (assuming 30 ml per fluid ounce) and adding 7.50 mis each of mineral oil, Aloe vera gel, and vitamin E oil adds about 4.7% ( ⁇ 1.6% each) relative to the volume of the dimethicone
  • Vitamin E source for example, an oil containing soybean oil, tocopheryl acetate, and coconut oil
  • Vitamin A source for example, an oil enriched for vitamin A (e.g., retinol palmitate) containing soybean oil and fish liver oil
  • water for example, spring or mineral water
  • mineral oil is added at a concentration of between about 0.2% to about 4% (Vol.:Vol.), or about 0.3% and about 3.2% (Vol.rVol.), or about 0.3% to about 4%, or about 3% to about 4%, or about 1% to about 2% (Vol.:Vol.), or about 0.3% (VoLrVoL), or about 1.6% (Vol.:VoL), or about 3.1% (VoLrVoL), with VoLrVoL being the volume of the mineral oil relative to the volume of the dimethicone/cyclomethicone mixture (e.g., adding 3.5 ml of mineral oil to 8 oz of the dimethicone/cyclomethicone mixture equals adding about 1.5% mineral oil).
  • Aloe vera is added at a concentration of between about 0.2% to about 4% (Vol.: Vol.), or about 0.3% and about 3.2% (Vol..-Vol.), or about 0.3% to about 4%, or about 3% to about 4%, or about 1% to about 2% (VoLrVoI.), or about 0.3% (VoLrVoL) 5 or about 1.6% (VoLrVoL), or about 3.1% (VoLrVoL) 3 with VoLrVoL being the volume of the Aloe vera relative to the volume of the dimethicone/cyclomethicone mixture.
  • a vitamin E source is added at a concentration of between about 0.2% to about 4% (VoLrVoL), or about 0.3% and about 3.2% (VoLrVoL), or about 0.3% to about 4%, or about 3% to about 4%, or about 1% to about 2% (VoLrVoL), or about 0.3% (VoLrVoL), or about 1.6% (VoLrVoL), or about 3.1% (VoLrVoL), with VoLrVoL being the volume of the vitamin E source relative to the volume of the dimethicone/cyclomethicone mixture.
  • a vitamin A source is added at a concentration of between about 0.1% to about 2% (Vol.: Vol.), or about 1% to about 2%, or about 0.3% to about 1.6%, or about 0.2% and about 1.6% (VoLrVoL), or about 0.26% (Vol.: Vol.), or about 0.78% (VoLrVoL), or about 1.56% (VoLrVoL), with VoLrVoL being the volume of the vitamin A source relative to the volume of the dimethicone/cyclomethicone mixture.
  • a scented oil is added at a concentration of between about 0.1% to about 2% (VoLrVoL), or about 1% to about 2%, or about 0.2% and about 1.6% (Vol.rVoL), or about 0.26% (Vol.rVol.), or about 0.78% (VoLrVoL), or about 1.56% (Vol.rVol.), with VoLrVoL being the volume of the scented oil relative to the volume of the dimethicone/cyclomethicone mixture.
  • water is added at a concentration of between about 0.05% to about .5% (Vol.rVol.), or about 0.1% to about 0.3%, or about 0.2% to about 0.3%, or about 0.13% to about 0.26%, or about 0.2%, or about 0.13%, or about 0.26% (Vol.:Vol.), with Vol.:Vol. being the volume of the water relative to the volume of the dimethicone/cyclomethicone mixture.
  • Vol.:Vol. being the volume of the water relative to the volume of the dimethicone/cyclomethicone mixture.
  • an additive selected from thie group consisting of zinc, iodine, rice extract, kelp extract, pumpkin seed extract and mixtures thereof may be added to any of the compositions of the invention.
  • a source of zinc is dissolved or suspended in a carrier and the dissolved or suspended solution is added to the composition.
  • an essential oil is added as desired for scent or softening properties to a composition of the invention comprising dimethicone, cyclomethicone, mineral oil, aloe vera gel, a vitamin E source, and a vitamin A source.
  • a zinc source may be added.
  • the composition comprises dimethicone and cyclomethicone in a ratio of about 3:1 or about 5:3 with one or more additional agents added according to the concentrations illustrated in Table 1:
  • the composition comprises dimethicone and cyclomethicone in a ratio of about 1:3 or about 3:5, which is preferably utilized as a hand lotion or for the treatment of cuticles, wherein the composition may have one or more additional agents added according to the concentrations illustrated in Table 2.
  • the composition comprises a mixture of dimethicone and cyclomethicone, Mineral Oil, Aloe Vera Gel, a Vitamin E source, a Vitamin A source, and water.
  • the composition comprises a mixture of dimethicone and cyclomethicone, Mineral Oil, Aloe Vera Gel, a Vitamin E source, a Vitamin A source, a scented oil and water.
  • the composition comprises a mixture of dimethicone and cyclomethicone, Mineral Oil, Aloe Vera Gel, a Vitamin E source, a Vitamin A source, a Zinc source and water.
  • the composition comprises a mixture of dimethicone and cyclomethicone, Mineral Oil, Aloe Vera Gel, a Vitamin E source, a Vitamin A source, a Zinc source, a scented oil and water.
  • the composition comprises a mixture of d ⁇ methicone and cyclomethicone, Mineral Oil, Aloe Vera Gel, a Vitamin E source, a Vitamin A source, water and an essential oil derived from a plant selected from the group consisting of Angelica Root, Anise, Peru Balsam, Basil, Bay, Bay Laurel, Beeswax, Benzoin, Bergamot, Bergamot Mint, Bois-de-rose, Boronia, Cajeput, Cardamum, Carrot Seed, Cedarwood, Chamomile, Cinnamon, Citronella, Clary Sage, Clove, Coriander, Cypress, Dill, Elemi, Eucalyptus, Fennel, Fir Needle, Frankincense, Galbanum
  • the composition comprises admixture of dimethicone and cyclomethicone, Mineral Oil, Aloe Vera Gel, a Vitamin E source, a Vitamin A source, water and an essential oil derived from lavender, wherein the composition may be used to treat pain.
  • compositions according to the invention may be made by mixing at moderate speed thereby introducing air into the composition.
  • the compositions according to the invention are mixed at moderate speed so as to introduce air into the composition wherein approximately 16 oz of starting material yields a volume of approximately 16.1 to about 16.8 oz, pr about 16.1, 16.2, 16.3, 16.4, 16.5, 16.6, 16.7, or 16.8 oz.
  • the invention also relates to a method of reducing symptoms in a subject believed to be suffering from or susceptible to a symptomatic state susceptible to treatment by a composition according to the invention, the method comprising: administering the composition according to the invention to an area of the skin or hair though to be in need of such treatment. :
  • composition of the invention may be used to treat burns, particularly minor burns, such as first or second degree burns, sunburns, eczema, psoriasis, dry or bleeding cuticles, dry or rough skin, athletes foot, razor rash or razor burn, cold sores, dry or chapped lips, and/or dry or frayed hair.
  • burns particularly minor burns, such as first or second degree burns, sunburns, eczema, psoriasis, dry or bleeding cuticles, dry or rough skin, athletes foot, razor rash or razor burn, cold sores, dry or chapped lips, and/or dry or frayed hair.
  • compositions of the invention will now be illustrated by way of the following illustrative Examples. : ⁇ !
  • An exemplary embodiment of the invention includes the following formulation: 6 ounces of Dimethicone; ;
  • Vitamin E source such as liquid vitamin E
  • Vitamin A oil 3.75 ml Vitamin A oil
  • Vitamin E oil 7.50 ml Vitamin E oil; 3.75 ml Vitamin A oil; 0.625 ml of perfume scented oil, (e.g., vanilla, musk, lilac, fruit scent, etc.); and 0.625 ml water.
  • perfume scented oil e.g., vanilla, musk, lilac, fruit scent, etc.
  • Another exemplary embodiment of the invention includes the following formulation: 12 ounces of Dimethicone; 4 ounces of Cyclomethicone; 1.50 ml Mineral Oil; 1.50 ml Aloe Vera Gel; 1.50 ml of a Vitamin E source (e.g., a soybean based vitamin E oil);
  • a Vitamin E source e.g., a soybean based vitamin E oil
  • a Vitamin A source e.g., a soybean based vitamin A oil where the vitamin A is derived from fish liver oil
  • 0.625 ml water 1.25 ml of a Vitamin A source (e.g., a soybean based vitamin A oil where the vitamin A is derived from fish liver oil); and 0.625 ml water.
  • compositions of the invention may be formulated as described in the present Example. However, as will be recognized by a person of skill in the art, the present method may be scaled up using equipment and techniques known in the art.
  • compositions of the invention are formulated by adding the silicone (dimethicone and cyclomethicone) ingredients as they are listed in Examples VI to X, mixing and or blending in a suitable container, blending at a high speed for not less than one minute, adding additional ingredients as listed in Examples VI to X one at a time and mixing and or blending in the same suitable container for not less than one minute after each ingredient is added, when all ingredients are added, blend or mix all ingredients together in same suitable container for not less than one minute, and transferring the composition into individual suitable bottles or containers and sealing the bottle or container.
  • silicone diimethicone and cyclomethicone
  • Another exemplary embodiment of the invention includes the following formulation: 6 ounces of 350 cSt Dimethicone;
  • This embodiment is preferably used as a topical agent on a subject's skin.
  • Vitamin A oil 3.75 ml Vitamin A oil; 3.25 ml lavender essential oil;
  • This embodiment is preferably used as a topical agent on a subject's skin.
  • This embodiment is preferably used to detangle, manage split ends and/or condition a subject's hair.
  • This embodiment is preferably used as a bath oil. .
  • Vitamin A oil 1.00 ml Vitamin A oil; and 0.625 ml spring water.
  • This embodiment is preferably used as a hand lotion, particularly for the treatment of dry or over grown cuticles.
  • Example XI Another exemplary embodiment of the invention includes the use of the composition to treat psoriasis and/or eczema.
  • the composition was applied to individuals suffering from psoriasis and/or eczema, including individuals having extreme cases of psoriasis and/or eczema resulting in itchy, scaly, rough, dry, sore, patchy plaques, bleeding, and/or oozing areas on the skin. After several treatments individuals reported that the skin appeared to be healing, that the soreness was relieved, and that the itching was absent. Most individuals who continued use of the composition for a period of four to six weeks reported that no psoriasis or eczema was apparent and the absence of further outbreaks.
  • the product was topically applied to an elderly lady believed to be suffering from psoriasis. This individual reportedly had been undergoing medical treatment for this condition for a period of four (4) years prior to the present treatment with little relief.
  • the prescribed treatment was said to require topical treatment at night, which comprised wrapping her arms and applying hot packs to them to prevent bleeding as she slept. Two weeks after applying the; present invention her face was clear, and within 4 weeks significant improvements in her arms were reported.
  • Another exemplary embodiment of the invention includes the use of the composition to treat minor burns.
  • the composition was applied to minor burns on individuals, particularly those causing small red marks or blisters on the skin, who reported that the burn sensation immediately went away and that with continued use the burn healed with little or no scaring.
  • compositions as an aid in the treatment of athletes feet.
  • the composition was applied twice daily to clean dry feet of individuals suffering from discomfort and odor associated with the infection. Individuals reported that the composition minimized the discomfort and/or soreness and that the odor was reduced or removed.
  • Example XIV Another exemplary embodiment of the invention includes the use of the composition as a lip gloss and/or treatment or preventative agent for chapped lips.
  • the composition was applied to chapped, sunburned and/or wind burned lips and was reported to relieve the symptoms.
  • the composition may be applied to an individual's lips, either alone or with lipstick or tint, to produce a desirable gloss and keep the lips soft.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne des compositions pour application externe sur la peau et/ou les cheveux. La composition peut être utilisée pour traiter des brûlures, en particulier des brûlures mineures, des coups de soleil, l'eczéma, le psoriasis, les cuticules sèches ou saignantes, la peau sèche ou rugueuse, le pied d'athlète, l'irritation du rasoir ou la brûlure du rasoir, l'herpès labial, les lèvres gercées ou sèches, les cheveux secs ou effilochés et/ou des combinaisons de ceux-ci.
PCT/US2006/048289 2005-12-19 2006-12-19 Produit de cosmetologie pour la peau et les cheveux WO2007075597A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75171405P 2005-12-19 2005-12-19
US60/751,714 2005-12-19

Publications (2)

Publication Number Publication Date
WO2007075597A2 true WO2007075597A2 (fr) 2007-07-05
WO2007075597A3 WO2007075597A3 (fr) 2008-06-26

Family

ID=38218517

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/048289 WO2007075597A2 (fr) 2005-12-19 2006-12-19 Produit de cosmetologie pour la peau et les cheveux

Country Status (1)

Country Link
WO (1) WO2007075597A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008115656A1 (fr) * 2007-02-22 2008-09-25 Healing Skin Llc Nouvelle composition de traitement d'une brûlure
US7858126B2 (en) 2006-08-31 2010-12-28 Trinity Laboratories Inc. Derivatives of sandalwood oil and santalols for treating cold sores and herpes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6830746B2 (en) * 2001-09-21 2004-12-14 Playtex Products, Inc. Sunscreen compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6830746B2 (en) * 2001-09-21 2004-12-14 Playtex Products, Inc. Sunscreen compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858126B2 (en) 2006-08-31 2010-12-28 Trinity Laboratories Inc. Derivatives of sandalwood oil and santalols for treating cold sores and herpes
WO2008115656A1 (fr) * 2007-02-22 2008-09-25 Healing Skin Llc Nouvelle composition de traitement d'une brûlure

Also Published As

Publication number Publication date
WO2007075597A3 (fr) 2008-06-26

Similar Documents

Publication Publication Date Title
US7060306B2 (en) Skin formulation
US5204105A (en) Cosmetic composition
CN105030610B (zh) 一种抗衰老组合物及其制备方法
US6193987B1 (en) Lubricating composition for hands and skin
EP3283053B1 (fr) Composition cosmétique à couches multiples
CN1156586A (zh) 含硅氧烷的纤细乳液及其在化妆品和皮肤病药物中的用途
CN105411919A (zh) 一种玫瑰护肤品及其制备方法
JPH09511763A (ja) 安定油中水エマルジョン系
TW200914056A (en) Stable high internal phase emulsions and compositions comprising the same
WO2001085156A1 (fr) Compositions dermiques ayant la coenzyme q comme principe actif
JP3894064B2 (ja) 油性増粘ゲル状組成物、該組成物を用いた乳化組成物及びその調製法
CN1246327A (zh) 含有颜料、防汗剂和部分交联的固体弹性有机聚硅氧烷的美容组合物及该组合物的用途
CN104940084A (zh) 纯天然浴后按摩油
CN1965791A (zh) 一种祛痘润肤乳及其制备方法
US20080145460A1 (en) Cosmetology product for skin and hair
WO2007075597A2 (fr) Produit de cosmetologie pour la peau et les cheveux
FR2767718A1 (fr) Emulsion eau-dans-huile comprenant de la silice pyrogenee et un alkylether de polysaccharide
US20010014343A1 (en) Skin care composition
CN105456124A (zh) 葡萄籽美白面膜
CN105106063A (zh) 含杜仲叶美白按摩霜
CN104940057A (zh) 月见草油洗面奶
EP1635853A2 (fr) Composition s'appliquant localement afin de traiter des lesions epidermiques et ses methodes d'utilisation
CN106344589A (zh) 一种稳定性改善的卡泊三醇倍他米松组合物
US20010005509A1 (en) Foot cream composition
CN104188882A (zh) 一种含有莳萝精油的护肤霜

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06845739

Country of ref document: EP

Kind code of ref document: A2